Iranian Journal of Immunology最新文献

筛选
英文 中文
The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study. 干扰素 Beta 和纳他珠单抗对复发性多发性硬化症患者 miR-20b 表达的影响可能是通过调节 Jak-STAT 信号通路介导的:一项病例对照研究。
IF 1.1 4区 医学
Iranian Journal of Immunology Pub Date : 2024-06-30 Epub Date: 2024-05-18 DOI: 10.22034/iji.2024.100500.2694
Aysan Jafari Harandi, Alireza Mirzaee Sedigh, Mitra Ataei, Sepideh Bayrami, Emran Esmaeilzadeh, Mohammad Hossein Sanati
{"title":"The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study.","authors":"Aysan Jafari Harandi, Alireza Mirzaee Sedigh, Mitra Ataei, Sepideh Bayrami, Emran Esmaeilzadeh, Mohammad Hossein Sanati","doi":"10.22034/iji.2024.100500.2694","DOIUrl":"10.22034/iji.2024.100500.2694","url":null,"abstract":"<p><strong>Background: </strong>The mechanisms of the function of interferon beta (IFN-β) and natalizumab (NTZ) in multiple sclerosis (MS) patients have not yet been fully understood. Over the past decades, many studies have been conducted to evaluate gene expression changes especially regulatory non-coding RNAs such as microRNAs (miRNAs) following therapy in MS patients.</p><p><strong>Objective: </strong>To assess the changes in the expression of miR-20b in MS patients treated with IFN-β or NTZ.</p><p><strong>Methods: </strong>Sixty patients with relapsing-remitting MS (RRMS) and 30 healthy controls (HCs) were enrolled. The patients were categorized as untreated (N=20), IFN-β-treated (N=20), and NTZtreated (N=20). For the expression analysis, real-time PCR was performed on the whole blood. The bioinformatic tools were applied for signaling pathways enrichment analysis of miR-20b targetome.</p><p><strong>Results: </strong>The relative expression of miR-20b was significantly downregulated in the untreated patients compared with the HCs (-1.726-fold, p<0.001), while IFN-β-treated and NTZ-treated patients showed no statistical difference compared with the HCs (0.733-fold, p=0.99 for IFN-β and 1.025-fold, p=0.18 for NTZ). This indicates the restoration of miR-20b expression to normal level in the treated patients. Additionally, in silico analysis demonstrated that the Jak-STAT signaling pathway is enriched with miR-20b targets (p<0.0001).</p><p><strong>Conclusion: </strong>Our findings suggest that the positive effects of IFN-β and NTZ in the RRMS patients could be potentially mediated by returning miR-20b expression to baseline.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis. 评估强直性脊柱炎患者的 PD-1 基因表达谱和调控区甲基化情况
IF 1.1 4区 医学
Iranian Journal of Immunology Pub Date : 2024-06-30 Epub Date: 2024-06-24 DOI: 10.22034/iji.2024.101565.2757
Narjes Soleimanifar, Sara Assadiasl, Mohammed Sameer Al-Shammari, Abdolrahman Rostamian, Maryam Sadr, Sepideh Shahkarami, Hanieh Mojtahedi, Mohammad Hossein Nicknam
{"title":"Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis.","authors":"Narjes Soleimanifar, Sara Assadiasl, Mohammed Sameer Al-Shammari, Abdolrahman Rostamian, Maryam Sadr, Sepideh Shahkarami, Hanieh Mojtahedi, Mohammad Hossein Nicknam","doi":"10.22034/iji.2024.101565.2757","DOIUrl":"10.22034/iji.2024.101565.2757","url":null,"abstract":"<p><strong>Background: </strong>Ankylosing spondylitis (AS) is a chronic autoimmune disorder characterized by the fusion of vertebral joints and axial arthritis. The programmed death-1 (PD-1) inhibitory receptor has a pivotal role in controlling T cell function and may have a significant impact on the pathogenesis of autoimmune diseases such as AS pathogenesis.</p><p><strong>Objective: </strong>To investigate PD-1 gene expression and its epigenetic regulation by detecting methylated CpG islands in the regulatory sites of the gene. This will provide insight into the mechanisms involved in the disease.</p><p><strong>Methods: </strong>30 AS patients and 30 healthy individuals were examined to detect the 16 CpG islands in intron 1 using bisulfite conversion and methylation-specific PCR technique. In addition, RNA samples were isolated from fresh peripheral blood mononuclear cells (PBMCs), and after complementary DNA (cDNA) synthesis, the expression level of the PD-1 gene was evaluated using Real-Time PCR.</p><p><strong>Results: </strong>The CpG islands located in the intronic zone of the PD-1 gene were hyper-methylated in both the patients with AS and the healthy controls. The gene expression of PD-1 was significantly downregulated in AS patients compared with the controls (p=0.017). A negative correlation between the Bath Ankylosing Spondylitis Disease Activity Index and PD-1 gene expression was also revealed.</p><p><strong>Conclusion: </strong>The low level of PD-1 gene expression is implicated in the pathogenesis of AS. However, in both groups, the methylation level of the intron 1 CpG islands of the PD-1 gene suggests that other regulatory mechanisms are more relevant to PD-1 gene expression than methylation in the intron.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer. 甘草提取物可调节乳腺癌动物模型中与 1 型 T 辅助细胞(TH1)和调节性 T 细胞相关的免疫反应
IF 1.1 4区 医学
Iranian Journal of Immunology Pub Date : 2024-06-30 Epub Date: 2024-05-27 DOI: 10.22034/iji.2024.101133.2735
Soheila Yousefi, Pedram Basirjafar, Raziyeh Zandvakili, Javad Masoumi, Nahid Zainodini, Hossein Khorramdelazad, Mahsa Gheitasi, Abdollah Jafarzadeh
{"title":"Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer.","authors":"Soheila Yousefi, Pedram Basirjafar, Raziyeh Zandvakili, Javad Masoumi, Nahid Zainodini, Hossein Khorramdelazad, Mahsa Gheitasi, Abdollah Jafarzadeh","doi":"10.22034/iji.2024.101133.2735","DOIUrl":"10.22034/iji.2024.101133.2735","url":null,"abstract":"<p><strong>Background: </strong>It is well-known that TH1 and Treg cells exert anti- and pro-tumorigenic activity, respectively. Thus, TH1 cell suppression together with Treg cell hyperactivation contribute to tumor development. Glycyrrhiza glabra (G. glabra) has various immunomodulatory and anti-tumorigenic properties.</p><p><strong>Objective: </strong>To explore the impacts of G. glabra extract on different parameters related to TH1 and Treg cells using a breast cancer (BC) model.</p><p><strong>Methods: </strong>Four groups of Balb/C mice bearing 4T1 cell-induced BC were treated intraperitoneally with either saline or G. glabra extract at dosages of 50, 100 and 150 mg/kg (G. glabra-50, G. glabra-100, and G. glabra-150, respectively). After sacrificing animals on day 26, the frequency of splenic TH1 and Treg cells, the levels of serum IFN-γ, TGF-β, and IL-12, and intra-tumoral expressions of granzyme-B, T-bet, and FOXP3 were assessed.</p><p><strong>Results: </strong>Compared to untreated tumor control (UTC) group, treatment with G. glabra-50, G. glabra-100, or G. glabra-150 increased the survival rate, percentage of TH1 cells, and T-bet expression. Conversely, they reduced the percentage of Treg cells, and serum TGF-β levels. In comparison to the UTC group, treatment with G. glabra-50 and G. glabra-150 increased the serum IL-12 levels. Treatment with G. glabra-100 and G. glabra-150 boosted granzyme-B expression. Treatment with G. glabra-150 elevated IFN-γ levels, while treatment with G. glabra-50 decreased the FOXP3 expression. IL-12 levels were higher in mice treated with G. glabra-150 compared to those treated with G. glabra-100.</p><p><strong>Conclusion: </strong>Treatment of mice with BC using G. glabra extract improved survival rate, reduced tumor growth, and modulated T cell-mediated immune responses.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study. 评估系统性硬化症患者的单核细胞亚群及其与疾病临床表现的关系:一项横断面对照研究。
IF 1.1 4区 医学
Iranian Journal of Immunology Pub Date : 2024-06-30 Epub Date: 2024-06-26 DOI: 10.22034/iji.2024.101590.2756
Elham Safarzadeh, Vahid Asghariazar, Shohreh Pordel, Elham Baghbani, Asgar Fekri, Afsaneh Enteshari-Moghaddam
{"title":"Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study.","authors":"Elham Safarzadeh, Vahid Asghariazar, Shohreh Pordel, Elham Baghbani, Asgar Fekri, Afsaneh Enteshari-Moghaddam","doi":"10.22034/iji.2024.101590.2756","DOIUrl":"10.22034/iji.2024.101590.2756","url":null,"abstract":"<p><strong>Background: </strong>Systemic sclerosis (SSc) is a chronic autoimmune disorder characterized not only by fibrosis and vasculopathy but also by inflammation. Previous studies have demonstrated monocyte involvement in SSc development, suggesting a role for immune dysfunction in SSc pathogenesis.</p><p><strong>Objective: </strong>To investigate the relationship between SSc's clinical manifestations and altered levels of monocyte subpopulations.</p><p><strong>Methods: </strong>Twenty-six patients meeting the ACR/EULAR SSc criteria along with twenty healthy individuals as the control group, were enrolled in the study. Peripheral blood mononuclear cells (PBMCs) were obtained from heparinized blood samples of both the SSc patients and the control group. Subpopulations of monocytes were assessed based on HLA-DR, CD14, and CD16 expression using multi-color flow cytometry. The one-way ANOVA, Student's t-test, and Mann-Whitney U test were employed for normally and non-normally distributed data. The Spearman correlation test was utilized to identify correlations between the variables.</p><p><strong>Results: </strong>The SSc patients showed a significant increase in the number of circulating peripheral blood monocytes (p<0.001). The percentage of CD16+ monocyte subpopulations was higher in the SSc cases compared to the control group. A significant decrease in the ratio of classic to non-classic monocytes was observed in SSc cases (7.43%) compared to the control group (52.09%, p<0.001). No association was observed between monocyte subpopulations and clinical characteristics of SSC.</p><p><strong>Conclusion: </strong>Our results showed an increase in the level of CD16+ monocytes in patients with SSc compared to healthy individuals. Further investigation is required to determine the clinical significance of this alteration.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Protective Role of IL-17 and IL-22 in COVID-19 Infection. IL-17 和 IL-22 在 COVID-19 感染中的保护作用
IF 1.1 4区 医学
Iranian Journal of Immunology Pub Date : 2024-06-26 DOI: 10.22034/iji.2024.100909.2721
Sengul Aksakal, Selim Gorgun
{"title":"The Protective Role of IL-17 and IL-22 in COVID-19 Infection.","authors":"Sengul Aksakal, Selim Gorgun","doi":"10.22034/iji.2024.100909.2721","DOIUrl":"10.22034/iji.2024.100909.2721","url":null,"abstract":"<p><strong>Background: </strong>The development of a cytokine storm in Coronavirus Disease 2019 (COVID-19) infection can make the disease fatal. We hypothesize that this excessive cytokine production impairs mucosal healing. IL-17 and IL-22 are cytokines that play a key role in protecting and regenerating mucosal tissues.IL-17 and IL-22 support each other and the imbalance between them plays a role in the pathogenesis of many rheumatologic diseases.</p><p><strong>Objective: </strong>To investigate whether COVID-19 severity is related to IL17, IL-22, and the IL-17/IL-22 ratio.</p><p><strong>Methods: </strong>The study was planned prospectively and included 69 patients with active COVID-19 infection.Three groups were created: patients with upper respiratory tract infection, pneumonia, and cytokine storm. Blood samples were taken from the patients upon their first admission and serum levels of IL-17 and IL-22 were measured using the enzyme-linked immunosorbent assay (ELISA). We assessed the relationship between IL17, IL22, IL17/IL22 ratio, clinical and lung involvement by comparing them with the healthy group.</p><p><strong>Results: </strong>The levels of IL-17 were significantly higher in COVID-19 patients with upper respiratory tract infection compared to the control group (p=0.027). IL17/IL-22 ratio significantly increased in patients with cytokine storm compared to the healthy controls (p=0.027). Serum levels of IL-22 were negatively correlated with the CO-RADS score (r=-0.31, p=0.004), while IL-17/IL-22 ratio was positively correlated with the CO-RADS score (r= 0.29, p=0.008).</p><p><strong>Conclusion: </strong>Levels of IL-17, IL-22 and IL-17/IL-22 may provide valuable insights into the progression of COVID-19.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value. 腺病毒肺炎患儿血清中 IL-13 和 IL-17A 水平的异常变化及其诊断价值
IF 0.9 4区 医学
Iranian Journal of Immunology Pub Date : 2024-03-12 DOI: 10.22034/iji.2024.99509.2648
Jianbo Jiang, Lili Sun, Meixia Huang
{"title":"Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value.","authors":"Jianbo Jiang, Lili Sun, Meixia Huang","doi":"10.22034/iji.2024.99509.2648","DOIUrl":"10.22034/iji.2024.99509.2648","url":null,"abstract":"<p><strong>Background: </strong>Human adenovirus (HAdV) is an enveloped icosahedral DNA virus. HAdV infection can lead to immune system damage, resulting in decreased numbers and compromised function of T cells and B cells. It can also cause an imbalanced Th1/Th2 ratio and dysregulation of pro-inflammatory and anti-inflammatory cytokines.</p><p><strong>Objective: </strong>To investigate the serum levels of interleukin (IL)-13 and IL-17A in children with HAdV pneumonia.</p><p><strong>Methods: </strong>Pediatric patients diagnosed with HAdV pneumonia were divided into a non-severe group or a severe group based on the severity of their condition. Patients in the severe group were further classified into good and poor prognosis subgroups. We collected 2-2.5 mL of venous blood from each patient, which was then centrifuged. Using an ELISA detection kit, we determined the concentrations of IL-13 and IL-17A.</p><p><strong>Results: </strong>Patients with a severe condition exhibited significantly higher serum concentrations of IL-13 and IL-17A than the non-severe cases. Out of 50 severe cases, 32 had good prognoses, while 18 cases showed poor prognoses. Patients with poor prognoses showed significantly higher serum concentrations of IL-13 compared to those with good prognoses.</p><p><strong>Conclusion: </strong>Serum concentrations of IL-13 and IL-17A are potential diagnostic markers for pediatric patients with severe HAdV pneumonia. Additionally, they demonstrate good predictive value for a poor prognosis in severe pneumonia cases.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor Regarding "Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity". 致编辑的信,内容涉及 "先天性免疫错误患者接种 COVID-19 疫苗后产生的抗体"。
IF 0.9 4区 医学
Iranian Journal of Immunology Pub Date : 2024-03-12 DOI: 10.22034/iji.2024.101588.2754
Nitin Deshpande
{"title":"Letter to the Editor Regarding \"Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity\".","authors":"Nitin Deshpande","doi":"10.22034/iji.2024.101588.2754","DOIUrl":"10.22034/iji.2024.101588.2754","url":null,"abstract":"","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140102892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage. 外周血自然杀伤细胞比率并非不明原因复发性流产的可靠替代免疫指标
IF 0.9 4区 医学
Iranian Journal of Immunology Pub Date : 2024-03-12 DOI: 10.22034/iji.2024.99305.2634
Niwei Yan, Pingyin Lee, Huiying Jie, Canquan Zhou, Yuan Yuan
{"title":"The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage.","authors":"Niwei Yan, Pingyin Lee, Huiying Jie, Canquan Zhou, Yuan Yuan","doi":"10.22034/iji.2024.99305.2634","DOIUrl":"10.22034/iji.2024.99305.2634","url":null,"abstract":"<p><strong>Background: </strong>Immunotherapies targeting peripheral natural killer (pbNK) cells in unexplained recurrent miscarriage (uRM) remain controversial. We hypothesized that the change in pbNK cell count might be a result of innate immune responses rather than a cause.</p><p><strong>Objective: </strong>To explore whether the pbNK count is significantly different in women testing positive than those testing negative for commonly studied autoimmune markers.</p><p><strong>Methods: </strong>Peripheral blood samples were collected from 302 eligible patients with uRM for the antinuclear antibody (ANA) testing determined by the enzyme-linked immunosorbent assay (ELISA), anti-thyroid peroxidase antibody (TPO-Ab) testing and anti-thyroglobulin antibody (Tg-Ab) testing determined by the chemiluminescent immunoassay, and pbNK cell testing determined by flow cytometry. The patients were divided into two groups according to the pbNK normal range, and the comparative analysis entailed an examination of the prevalence rates of autoantibodies within the high pbNK group and the normal pbNK group, followed by a comprehensive investigation into the potential correlations between autoantibodies and pbNK cells.</p><p><strong>Results: </strong>There was a positive association between TPO-Ab positivity and high pbNK cells (p=0.016, OR=5.097, 95% CI 1.356-19.159), while there was a negative association between ANA positivity and high pbNK cells (p=0.013, OR=0.293, 95% CI 0.111-0.773). TPO-Ab-positive patients had a higher pbNK cell count compared with TPO-Ab-negative patients, while ANA-positive patients had a lower pbNK cell count compared with ANA-negative patients.</p><p><strong>Conclusion: </strong>The change in pbNK cell count may be a consequence of immune responses, and there should be careful consideration in applying it as an immunotherapeutic index.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma. 用 ICOSL 抗体干预可缓解中性粒细胞性哮喘小鼠的炎性浸润。
IF 0.9 4区 医学
Iranian Journal of Immunology Pub Date : 2024-03-12 DOI: 10.22034/iji.2024.98853.2594
Heting Dong, Yinying Ren, Yiyi Song, Wei Ji, Yongdong Yan, Canhong Zhu, Li Huang, Meijuan Wang, Wenjing Gu, Xinxing Zhang, Huiming Sun, Chuangli Hao, Zhengrong Chen
{"title":"Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma.","authors":"Heting Dong, Yinying Ren, Yiyi Song, Wei Ji, Yongdong Yan, Canhong Zhu, Li Huang, Meijuan Wang, Wenjing Gu, Xinxing Zhang, Huiming Sun, Chuangli Hao, Zhengrong Chen","doi":"10.22034/iji.2024.98853.2594","DOIUrl":"10.22034/iji.2024.98853.2594","url":null,"abstract":"<p><strong>Background: </strong>Neutrophilic asthma is characterized by the predominant infiltration of neutrophils in airway inflammation.</p><p><strong>Objective: </strong>To explore the therapeutic potential of an antibody against the inducible T cell co-stimulator ligand (ICOSL) in a mouse model of neutrophilic asthma.</p><p><strong>Methods: </strong>Female BALB/c mice were randomly assigned to different groups. They were then injected with ovalbumin (OVA)/lipopolysaccharides (LPS) to induce neutrophilic asthma. The mice were then treated with either anti-ICOSL (the I group), control IgG (the G group), or no treatment (the N group). Additionally, a control group of mice received vehicle PBS and was labeled as the C group (n=6 per group). One day after the last allergen exposure, cytokine levels were measured in plasma and bronchoalveolar lavage fluid (BALF) using ELISA. After analyzing and categorizing BALF cells, the lung tissues were examined histologically and immunohistochemically.</p><p><strong>Results: </strong>Administering anti-ICOSL resulted in a significant decrease in the total number of inflammatory infiltrates and neutrophils found in BALF. Moreover, it led to a decrease in the levels of interleukin (IL)-6, IL-13, and IL-17 in both BALF and plasma. Additionally, there was an increase in IFN-γ levels in the BALF of asthmatic mice (p<0.05 for all). Treatment with anti-ICOSL also reduced lung interstitial inflammation, mucus secretion, and ICOSL expression in asthmatic mice.</p><p><strong>Conclusion: </strong>The treatment of anti-ICOSL effectively improved lung interstitial inflammation and mucus secretion in mice with neutrophilic asthma by restoring the balance of Th1/Th2/Th17 responses. These findings indicate that blocking the ICOS/ICOSL signaling could be an effective way to manage neutrophilic asthma.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17. 微RNA-150缺失可通过抑制IL-17降低类风湿关节炎的发生率和严重程度
IF 0.9 4区 医学
Iranian Journal of Immunology Pub Date : 2024-03-12 DOI: 10.22034/iji.2024.99855.2666
Aihong Zhang, Quanhui Zheng
{"title":"MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17.","authors":"Aihong Zhang, Quanhui Zheng","doi":"10.22034/iji.2024.99855.2666","DOIUrl":"10.22034/iji.2024.99855.2666","url":null,"abstract":"<p><strong>Background: </strong>Understanding the effects of epigenetic factors on the pathogenesis of rheumatoid arthritis (RA) is important for the early diagnosis and therapeutic intervention of this disease. MicroRNA-150 (miR-150) exerts an important influence on the development and function of lymphocytes. However, the role of miR-150 in the pathogenesis of RA remains unclear.</p><p><strong>Objective: </strong>To explore the role of miR-150 in the pathogenesis of RA and the related immune mechanism.</p><p><strong>Methods: </strong>In this study, we used miR-150 knock-out (miR-150KO) and created animal models of RA. Flow cytometry, immunohistochemistry, and real-time RT-PCR were employed to assess the frequency of T cell subsets and cytokines expression.</p><p><strong>Results: </strong>Compared to wild-type (WT) mice, the onset of RA was postponed and the incidence of RA was reduced in miR-150KO mice. The expression of IL-4 and IFN-γ significantly increased while the expression of IL-17 decreased significantly in NKT and CD4+ T cells of KO mice compared to that of WT mice after RA induction. In addition, the expression of IL-4 and IFN-γ increased while the expression of IL-17 decreased significantly in the joint tissues of KO mice compared to that of WT mice. Furthermore, the mRNA expression of TNF-α and IL-17 decreased significantly in the synovial fluid cells of KO mice compared to that of the WT mice after RA induction.</p><p><strong>Conclusion: </strong>MiR-150 deficiency decreases the expression of IL-17 in T cells and joint tissues, and alleviates the occurrence and progression of RA in mice.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信